Skip to main content

Day: April 3, 2020

Primo Nutraceuticals Inc., Signs Share Acquisition LOI with Celebrity brand Beauty Kitchen

VANCOUVER, British Columbia, April 03, 2020 (GLOBE NEWSWIRE) — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) Pursuant to discussions with IIROC (Investment Industry Regulatory Organization of Canada) Primo’s board and management team are providing more clarity to its shareholders in regards to the press release issued on March 31st, 2020.The Company has signed a non-binding letter of intent (LOI) with Heather Marianna, LLC, doing business as Beauty Kitchen, a Nevada company, (“Beauty Kitchen”).  The LOI is non-binding and subject to possible change and the signing of a definitive agreement.Primo and Beauty Kitchen intend to draft and execute a definitive agreement (the “Definitive Agreement”) with detailed terms and conditions in the...

Continue reading

Banco Comercial Português, S.A. informs about Fitch Rating Actions

Banco Comercial Português, S.A. (“Bank”) informs that Fitch Ratings, which has recently been revising the ratings of the European banks in different geographies due to the disruption caused by the coronavirus outbreak, also made a reassessment of the Portuguese market and communicated the following rating actions on the Bank:Affirmed BCP’s Long-Term Rating of ‘BB’ (“IDR” – Issue Default Rating) and its Intrinsic Rating of ‘bb’ (“VR” – Viability Rating), and revised the Outlook to Negative from Positive, reflecting the uncertainty related to the coronavirus crisis;Assigned a ‘BB-’ rating to the Bank’s senior non-preferred debt and a ‘B+’ rating to its tier 2 debt, according to Fitch’s new rating methodology for banks;Assigned a ‘BB+’/‘B’ rating to the Bank’s deposits, one notch above the Long-Term IDR, reflecting the view of Fitch...

Continue reading

Banco Comercial Português, S.A. informa sobre ações de rating da Fitch Ratings

O Banco Comercial Português, SA (“Banco”) informa que a Fitch Ratings que, recentemente, tem vindo a rever os ratings da banca europeia em diferentes geografias, motivada pela disrupção causada pelo surto de coronavírus, fez também uma reavaliação do mercado português e comunicou as seguintes ações de rating sobre o Banco:Reafirmou o rating de longo prazo do Banco em ‘BB’ (“IDR” – issuer default rating) e o seu rating intrínseco em ‘bb’ (“VR” – viability rating), e reviu o outlook de longo prazo de Positivo para Negativo, com base na incerteza associada ao coronavírus;Atribuiu o rating ‘BB-’ à dívida sénior não preferencial do Banco, e o rating ‘B+’ à dívida Tier 2, de acordo com a sua nova metodologia de rating de bancos;Atribuiu o rating ‘BB+’/ ‘B’ aos depósitos, um nível acima do IDR de longo prazo, refletindo a visão da...

Continue reading

Jones Soda Revs Up Marketing with Torque Esports Sponsorship

SEATTLE, April 03, 2020 (GLOBE NEWSWIRE) — Jones Soda Co. (the “Company”) (OTCQB: JSDA), a leader in the craft soda industry known for its unique branding and authentic connection to consumers, is reaching the virtual racing community for the first time through a partnership with Torque Esports. The company is the title sponsor for the Last Chance Qualifier competition in The Race All-Star Series, a five-week esports sim racing series that is gaining strong viewership among motorsports fans in the wake of coronavirus-related cancellations of live events.Each week’s races have generated up to 12.1 million minutes watched on the event’s YouTube channel, including nearly 30,000 combined comments and millions of impressions on social media. Viewers are drawn in part because of participation by racing superstars from NASCAR, IndyCar,...

Continue reading

Fitch Downgrades Ferratum to B+/Negative on Coronavirus Disruption

Fitch Downgrades Ferratum to B+/Negative on Coronavirus DisruptionHelsinki, 3 April 2020 – Ferratum Oyj (ISIN: FI4000106299, WKN: A1W9NS) (“Ferratum” or the “Group”) announces that Fitch Ratings has downgraded Ferratum Oyj’s Long-Term Issuer Default Rating (IDR) and the Long Term rating of senior unsecured notes issued by Ferratum Capital Germany GmbH from ‘BB-‘ outlook stable to ‘B+’/RR4 on increasing coronavirus-related risks. The Outlook on Ferratum’s Long-Term IDR is Negative.About Ferratum Group:Ferratum Group is an international provider of mobile banking and digital consumer and small business loans, distributed and managed by mobile devices. Founded in 2005 and headquartered in Helsinki, Finland, Ferratum has expanded rapidly to operate in 23 countries across Europe, Africa, South and North America, Australia and Asia.As a pioneer...

Continue reading

Communiqué – Business & Decision, dépôt d’un projet de note d’information

COMMUNIQUE DE PRESSE DU 3 AVRIL 2020DEPOT D’UN PROJET DE NOTE D’INFORMATIONETABLI PAR LA SOCIÉTÉBusiness & DecisionEN RÉPONSE AU PROJET D’OFFRE PUBLIQUE DE RETRAIT VISANT SES ACTIONS INITIÉE PAR ORANGE BUSINESS SERVICES, FILIALE DEOrangeET PRÉSENTÉE PARPortzamparc BNP ParibasETABLISSEMENT PRÉSENTATEUR ET GARANTAMFLe présent communiqué a été établi et diffusé le 3 avril 2020 par la société Business & Decision conformément aux dispositions de l’article 231-26 du règlement général de l’Autorité des Marchés Financiers (« AMF »).L’OFFRE ET LE PROJET DE NOTE EN REPONSERESTENT SOUMIS À L’EXAMEN DE L’AMFLes exemplaires du projet de note en réponse (le « Projet de Note en Réponse ») sont disponibles sur le site Internet de l’AMF (www.amf-france.org) et de la société Business & Decision (https://fr.group.businessdecision.com)...

Continue reading

CytoDyn CEO Dr. Pourhassan Appearance on Fox Business Network Rescheduled to April 8 Same Time (11am PT); CytoDyn will Reveal Today the Name of the Hospital and the Physician who Treated 10 Patients During an Interview on Seattle-Affiliate of CBS News which Will Air Between 5-6:30 p.m. PT

VANCOUVER, Washington, April 03, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn, will be rescheduled to appear on Fox Business Network on the “Making Money with Charles Payne” program on April 8 and a second interview and will also available via live streaming at https://www.foxbusiness.com/shows/making-money-with-charles-payne.Although Dr. Pourhassan’s appearance has been re-scheduled, the CytoDyn team wishes to take this opportunity to express its deep gratitude and appreciation to the hospital, the physician, and his medical team for their heroic efforts...

Continue reading

Akerna Flash Report: In Q1 2020 Women Outspent Men on Cannabis

DENVER, April 03, 2020 (GLOBE NEWSWIRE) — Business intelligence from Akerna (Nasdaq: KERN), a leading compliance technology provider and developer of the cannabis industry’s first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®) shows women, across all age groups 18-55+ drove cannabis sales in the first quarter, 2020. The average amount spent by women increased by 50% in March.*The Numbers, Q1 2020 :Total cannabis sales increased in Q1 2020 by 16% over Q4 2019. The top products purchased in Q1 in each category:Concentrates:         8% of purchases for women and  12% of purchases for menEdibles:                 12% of purchases for women and 8% of purchases for menFlower:                  40% of purchases for women and 45% of purchases for menVape:                     39% of purchases for women and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.